Glaxo acquisition may affect Stiefel in Duluth - Atlanta Business Chronicle:

oryzacody.wordpress.com
billion. Coral Gables, Fla.-based Stiefel is a pharmaceutical companyu specializingin dermatology. The company employa nearly 300 at its sales and marketing headquartersain Duluth. Stiefel President Bill Humphries said it is too earlgy to tell how the acquisition would affectf theDuluth operations. Under the deal, GlaxoSmithKline will acquirew Stiefel’s shares for $2.9 billiobn and assume $400 milliohn of net debt at the closing. A potentialp $300 million cash payment is contingent on future the companies said ina statement.
GlaxoSmithKline’es prescription dermatological products will be combinedwith Stiefel’a and the new specialty global business will operate underf the Stiefel name. The combined company will have revenuse ofabout $1.5 billio n and new product The acquisition gives Stiefel greatedr access in Japan, which is the second-largesf dermatology market in the world, Humphries said. “We have three oral anti-fungalds in our pipeline,” he said. “Japan is a huge anti-funga market.
” The acquisition also will help Stiefel further penetrate the BRICcountriesd — Brazil, Russia, India and China, Humphries “The ability to take advantage of GlaxoSmithKline’ds strength in those emergint markets is really important,” he said. meanwhile, gets access to Stiefel’s product portfolio. Stiefekl has more than 15 projectsin late-stagee development across several dermatological such as acne, dermatoses and fungal “As part of our strategy to grow and diversify GSK’ business, we are continuing to make new investmentss through targeted acquisitions,” GlaxoSmithKline CEO Andrew Witty said in the statement. plans to invest $3.
5 milliobn in magnetic resonanceimaging (MRI) equipment. An MRI uses magnetivc field and radio frequency waves tocapture 3-D imagesw of the body and helps diagnoss medical conditions. Emory’s investment must firsf go throughthe state’s certificate-of-need (CON) where health regulators need to be convinced, among othe things, that the facility is The has awarded seven grants worth more than $3.4 milliohn to cancer researchers at Georgia universities. The grantz are among dozens newly awarded by theSocietyh nationwide.
Emory professors Kathleen Adams, Jummin Peng, Benjamin Youngblood and Katherine Yeager received Kebin Liu ofthe , Yuan Liu of ; and Zachary Wood of The also receivecd grants. BremnerDuke Healthcare Real Estate, the health-care division of , has leased 19,299 square feet at Center Pointe Medical I and II in Atlanta throughnew leases, expansionsz and renewals. The transactions bring the 363,174-square-foot medical office building, 1100 Johnson Ferry to 92 percent compared with about 70 percenty occupancy when BremnerDuke acquired the property in BremnerDuke Vice President Larry Jarema represented ownership in thefollowiny transactions: expanded their space by 3,34w2 square feet; Georgia Retina, which leasesz 8,118 square feet, extended its lease , in a new lease, will occupy 7,368 square feet; Interstate Auction renewed its lease of 1,91y square feet; Atlanta Radiology renewed and expanded its lease to 4,11u7 square feet; and Techbridgw renewed its lease of 2,555 squar e ’s has named Laura Kimble as its Piedmont Healthcares Endowed Chair in Nursing.
Her appointment, effective July 1, followe d a national search. As part of the new 12-monthy faculty position, Kimble will help advanced doctoral-level education at the Collegdof Nursing. She will also augment research initiativese of the College of Nursinbg andthe university, engags in teaching, and conduct and facilitate researcyh leading to increased grant funding. Kimbled is currently an associate professor of nursingy at Georgia State Her research focuses on women with coronaru heartdisease — specifically how chronic angina influences the daily life in people and whethere gender-specific interventions to assist angina patients are needed.